Table 3.
Unadjusted | Adjusted |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1† | Model 2‡ | Model 3§ | |||||||||||||
Variables | β | 95% CI | P | B | 95% CI | P | % Red¶ | β | 95% CI | P | % Red¶ | β | 95% CI | P | % Red¶ |
Clinical features | |||||||||||||||
Fever | 0.08 | −0.01, 0.18 | 0.094 | 0.03 | −0.06, 0.12 | NS | 61 | 0.05 | −0.04, 0.14 | NS | 36.3 | 0.04 | −0.06, 0.14 | NS | 46 |
Discoid rash | 0.14 | 0.03, 0.26 | 0.015 | 0.03 | −0.08, 0.14 | NS | 80 | 0.01 | −0.10, 0.13 | NS | 90.8 | 0.04 | −0.08, 0.15 | NS | 75 |
Raynaud phenomenon | −0.09 | −0.18, 0.00 | 0.053 | −0.02 | −0.11, 0.06 | NS | 73 | −0.04 | −0.13, 0.06 | NS | 60.7 | −0.04 | −0.13, 0.06 | NS | 61 |
Livedo reticularis | −0.13 | −0.24, −0.03 | 0.013 | −0.05 | −0.15, 0.06 | NS | 65 | −0.08 | −0.19, 0.04 | NS | 43.6 | −0.07 | −0.19, 0.04 | NS | 44 |
Pericarditis | 0.13 | 0.02, 0.23 | 0.023 | 0.09 | −0.01, 0.19 | 0.071 | 27 | 0.04 | −0.06, 0.15 | NS | 64.8 | 0.05 | −0.06, 0.16 | NS | 60 |
Myocarditis | 0.41 | 0.08, 0.73 | 0.014 | 0.39 | 0.10, 0.68 | 0.009 | 3 | 0.44 | 0.13, 0.76 | 0.006 | −9.1 | 0.57 | 0.22, 0.92 | 0.002 | −39 |
Murmur | 0.21 | 0.12, 0.29 | <0.001 | 0.11 | 0.02, 0.20 | 0.019 | 47 | 0.15 | 0.05, 0.25 | 0.003 | 27.3 | 0.16 | 0.06, 0.26 | 0.002 | 22 |
Pleuritis | 0.10 | 0.01, 0.19 | 0.036 | 0.09 | 0.01, 0.18 | 0.032 | 6 | 0.10 | 0.01, 0.19 | 0.031 | −2.1 | 0.08 | −0.01, 0.18 | 0.094 | 17 |
Interstitial pulmonary fibrosis | 0.25 | 0.08, 0.41 | 0.003 | 0.18 | 0.03, 0.33 | 0.019 | 27 | 0.16 | −0.00, 0.32 | 0.051 | 35.9 | 0.17 | 0.01, 0.33 | 0.043 | 31 |
Pulmonary hypertension | 0.24 | 0.08, 0.41 | 0.003 | 0.10 | −0.05, 0.25 | NS | 59 | 0.15 | −0.01, 0.31 | 0.066 | 38.7 | 0.18 | 0.01, 0.34 | 0.036 | 27 |
Colitis, vasculitis, and serositis | 0.24 | 0.05, 0.44 | 0.013 | 0.21 | 0.03, 0.38 | 0.021 | 16 | 0.26 | 0.06, 0.46 | 0.012 | −5.3 | 0.28 | 0.07, 0.49 | 0.008 | −15 |
Seizure | 0.21 | 0.04, 0.39 | 0.019 | 0.23 | 0.07, 0.39 | 0.006 | −7 | 0.19 | 0.02, 0.36 | 0.027 | 9.9 | 0.17 | −0.01, 0.35 | 0.069 | 22 |
Anemia | 0.14 | 0.05, 0.23 | 0.003 | 0.07 | −0.02, 0.16 | NS | 48 | 0.09 | −0.00, 0.19 | 0.055 | 32.8 | 0.12 | 0.02, 0.22 | 0.021 | 14 |
Autoantibodies | |||||||||||||||
Anti-dsDNA | 0.00 | 0.00, 0.00 | <0.001 | 0.00 | 0.00, 0.00 | <0.001 | 0 | 0.00 | 0.00, 0.00 | <0.001 | 0 | 0.00 | 0.00, 0.00 | <0.001 | 0 |
Lupus anticoagulant | 0.18 | 0.08, 0.28 | <0.001 | 0.13 | 0.04, 0.22 | 0.007 | 28 | 0.14 | 0.04, 0.24 | 0.006 | 22.8 | 0.13 | 0.03, 0.24 | 0.013 | 26 |
Abbreviations:β, regression coefficient; CI, confidence interval; NS, not significant.
Log-transformed values of hsCRP ranged from −1.00 to 1.93.
Model 1: Adjusted for age, gender, ethnicity, disease duration, body mass index, and education
Model 2: Adjusted for age, gender, ethnicity, disease duration, body mass index, education, and SELENA-SLEDAI.
Model 3: Adjusted for age, gender, ethnicity, disease duration, body mass index, education, SELENA-SLEDAI, current prednisone dose, statin use, and estrogen use.
Percentage reduction in regression coefficients from the unadjusted model, calculated as: (regression coefficientunadjusted − regression coefficientmodel 1 or 2 or 3)/(regression coefficientunadjusted).